Antiviral monoclonal antibody cocktails as a modern weapon in combating pandemics

Dingjiang Liu; Mohammed Shameem

doi:10.4155/tde-2021-0079

Antiviral monoclonal antibody cocktails as a modern weapon in combating pandemics

Dingjiang Liu
, Mohammed Shameem

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Original language	English
Pages (from-to)	67-69
Number of pages	3
Journal	Therapeutic Delivery
Volume	13
Issue number	2
DOIs	https://doi.org/10.4155/tde-2021-0079
State	Published - Feb 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Antibody cocktail
REGEN-COV
SARS-CoV-2
antiviral
coformulation
formulation
high concentration
monoclonal antibody
pandemic

ASJC Scopus subject areas

Pharmaceutical Science

Access to Document

10.4155/tde-2021-0079

Cite this

@article{b9b9f6bcb1b041fbaaa6d5922354ccad,

title = "Antiviral monoclonal antibody cocktails as a modern weapon in combating pandemics",

keywords = "Antibody cocktail, REGEN-COV, SARS-CoV-2, antiviral, coformulation, formulation, high concentration, monoclonal antibody, pandemic",

author = "Dingjiang Liu and Mohammed Shameem",

year = "2022",

month = feb,

doi = "10.4155/tde-2021-0079",

language = "English",

volume = "13",

pages = "67--69",

journal = "Therapeutic Delivery",

issn = "2041-5990",

publisher = "Taylor and Francis Ltd.",

number = "2",

}

TY - JOUR

T1 - Antiviral monoclonal antibody cocktails as a modern weapon in combating pandemics

AU - Liu, Dingjiang

AU - Shameem, Mohammed

PY - 2022/2

Y1 - 2022/2

KW - Antibody cocktail

KW - REGEN-COV

KW - SARS-CoV-2

KW - antiviral

KW - coformulation

KW - formulation

KW - high concentration

KW - monoclonal antibody

KW - pandemic

UR - https://www.scopus.com/pages/publications/85124444758

U2 - 10.4155/tde-2021-0079

DO - 10.4155/tde-2021-0079

M3 - Review article

C2 - 34726506

AN - SCOPUS:85124444758

SN - 2041-5990

VL - 13

SP - 67

EP - 69

JO - Therapeutic Delivery

JF - Therapeutic Delivery

IS - 2

ER -